Definium Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Definium Therapeutics, Inc. (DFTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.41 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 1.05M shares, a 10.61% decline year-over-year.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 357.61K shares, a 52.67% decline year-over-year.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 332.35K shares, a 40.48% decline year-over-year.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 783.40K shares, a 179.99% increase year-over-year.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 3.05M shares, a 16.13% increase from fiscal 2024.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.63M shares.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 990.01K shares, a 95.10% decline from fiscal 2021.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 20.19M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.05M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 1.41M shares 10-Q · filed 2026-08-06 | 1.74M shares derived: sum of 3 quarters · filed 2026-08-06 | 2.53M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 357.61K shares 10-Q · filed 2026-05-07 | 689.96K shares derived: sum of 2 quarters · filed 2026-05-07 | 1.47M shares derived: sum of 3 quarters · filed 2026-05-07 | 2.65M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 332.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 1.12M shares derived: sum of 2 quarters · filed 2026-02-26 | 2.30M shares derived: sum of 3 quarters · filed 2026-02-26 | 3.05M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 783.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 1.96M shares derived: sum of 2 quarters · filed 2025-11-06 | 2.72M shares 10-Q · filed 2025-11-06 | 3.28M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 1.18M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | 1.94M shares 10-Q · filed 2025-07-31 | 2.49M shares derived: sum of 3 quarters · filed 2025-07-31 | 2.77M shares derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | 755.50K shares 10-Q · filed 2025-05-08 | 1.31M shares derived: sum of 2 quarters · filed 2025-05-08 | 1.59M shares derived: sum of 3 quarters · filed 2025-05-08 | 1.68M shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 558.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 838.20K shares derived: sum of 2 quarters · filed 2025-03-06 | 920.73K shares derived: sum of 3 quarters · filed 2025-03-06 | 2.63M shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 279.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 362.33K shares derived: sum of 2 quarters · filed 2024-11-07 | 2.07M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 82.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 1.79M shares 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | 1.71M shares 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | 30.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -9.39M shares derived: sum of 2 quarters · filed 2023-03-09 | -7.37M shares derived: sum of 3 quarters · filed 2023-03-09 | 990.01K shares 10-K · filed 2023-03-09 |
| 2022-09-30 | -9.42M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -7.40M shares derived: sum of 2 quarters · filed 2022-11-10 | 959.61K shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 2.02M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 10.38M shares 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | 8.36M shares 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | 20.19M shares 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |